Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease
- 1 February 1981
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 21 (4-5) , 357-365
- https://doi.org/10.1016/0049-3848(81)90136-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Release of Plasminogen Activator and Factor VIII after Injection of DDAVP in Healthy Volunteers and in Patients with von Willebrand's DiseaseScandinavian Journal of Haematology, 1980
- Von willebrand disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII proteinAmerican Journal of Hematology, 1980
- Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.The Tohoku Journal of Experimental Medicine, 1980
- Specificity in the Factor VIII Response to Vasopressin Infusion in ManBritish Journal of Haematology, 1979
- DDAVP in Von Willebrand's disease: Repeated administration and the behaviour of the bleeding timeThrombosis Research, 1978
- DDAVP: Alternative zur Substitutionsbehandlung bei leichter Hämophilie A und von-Willebrand-Jürgens-SyndromDeutsche Medizinische Wochenschrift (1946), 1977
- D.D.A.V.P. IN HÆMOPHILIAThe Lancet, 1977
- D.D.A.V.P. IN HÆMOPHILIAThe Lancet, 1977
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975